Dalmia Bharat Sugar and Industries Limited
DALMIASUG · NSE · Consumer Defensive
With a 20% margin of safety, our buy-below price is ₹543.12. Low-confidence estimate — limited data.
Piotroski F-score 3/9 — quality of earnings & balance sheet.
Investability checklist
- ✕ROE above 15%7.3%
- ✕Low debt (D/E < 0.5)0.56x
- ✕Positive free cash flow
- ✕Revenue growth > 10%-3%
- ✕Earnings growing-50%
- ✕Net margin ≥ 10%6.5%
- ✓Current ratio > 1.51.58
- ✓Below our fair value
- ✓Margin of safety ≥ 20%
- ✓Above 200-day average
- ✕Above 50-day average
- –Positive 1-year return
- ✕Altman Z in safe zoneZ 2.26
- ✕Piotroski ≥ 73/9
1-year price
EOD · 2026-06-16Our scores
Durability rewards strong, low-debt, profitable businesses; Valuation rewards stocks cheap vs their sector; Momentum rewards strong price trends.
Quarterly results
Annual financials
Shareholding
Promoter holding via insider stake; institutional via reported holdings.
Analyst views
Key fundamentals
SWOT snapshot
Weaknesses
- •Low return on equity (7.3%).
- •Weak Piotroski score (3/9).
Opportunities
- •Trading in our value buy zone versus sector peers.
- •Trades ~100% below our estimated fair value.
Threats
- •Earnings contracting year on year.
About Dalmia Bharat Sugar and Industries Limited
Dalmia Bharat Sugar and Industries Limited engages in the sugar business in India and internationally. It operates through Own Manufactured Sugar, Distillery, and Others segments. The company offers refined sugar and double sulphitation sugars; by-products, such as bagasse and molasses to generate power; alcohol-based hand sanitizers; and sulphur free white crystal sugar and natural brown sugar under the Dalmia Utsav brand name
More in Consumer Defensive
Our verdict, fair value, financial-health and checklist are StocksWizard's own estimates, computed from public end-of-day data using standard models (DCF, relative valuation, Altman Z, Piotroski). For information only — not investment advice or a recommendation. Verify independently before investing.